Amgen Target price 2024 - Analyst rating & recommendation
Amgen Classifications & Recommendation:
Amgen Price Target
| Target Price | $317.30 |
| Price | $310.88 |
| Potential | 2.06% |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target Amgen 2025 . The average Amgen target price is $317.30. This is 2.06% higher than the current stock price. The highest price target is $380.00 22.23% , the lowest is $170.00 45.32% . | |
| A rating was issued by 29 analysts: 14 Analysts recommend Amgen to buy, 13 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Amgen stock has an average upside potential 2025 of 2.06% . Most analysts recommend the Amgen stock at Purchase. |
Sales and Margin forecast 2024, 2025 to 2028
25 Analysts have issued a sales forecast Amgen 2024 . The average Amgen sales estimate is $33.0b . This is 12.42% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $33.9b 15.41% , the lowest is $32.6b 10.98% .
This results in the following potential growth metrics:
Revenue Estimates
| 2023 | $28.0b | 7.35% |
|---|---|---|
| 2024 | $33.0b | 17.81% |
| 2025 | $34.0b | 3.14% |
| 2026 | $34.7b | 1.91% |
| 2027 | $35.0b | 0.90% |
| 2028 | $35.3b | 0.83% |
6 Analysts have issued an Amgen EBITDA forecast 2024. The average Amgen EBITDA estimate is $19.8b . This is 67.16% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $23.4b 96.94% , the lowest is $18.4b 55.35% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2023 | $12.4b | 1.91% |
|---|---|---|
| 2024 | $19.8b | 60.45% |
| 2025 | $18.6b | 6.24% |
| 2026 | $18.7b | 0.71% |
| 2027 | $18.8b | 0.25% |
| 2028 | $18.6b | 0.63% |
EBITDA Margin
| 2023 | 44.11% | 8.62% |
|---|---|---|
| 2024 | 60.08% | 36.20% |
| 2025 | 54.61% | 9.10% |
| 2026 | 53.97% | 1.17% |
| 2027 | 53.62% | 0.65% |
| 2028 | 52.84% | 1.45% |
11 Amgen Analysts have issued a net profit forecast 2024. The average Amgen net profit estimate is $4.6b . This is 23.17% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $7.9b 111.73% , the lowest is $3.8b 2.43% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2023 | $6.7b | 3.14% |
|---|---|---|
| 2024 | $4.6b | 31.07% |
| 2025 | $5.9b | 28.59% |
| 2026 | $6.8b | 14.18% |
| 2027 | $9.5b | 40.26% |
| 2028 | $9.8b | 3.26% |
Net Margin
| 2023 | 23.92% | 3.92% |
|---|---|---|
| 2024 | 13.99% | 41.51% |
| 2025 | 17.45% | 24.73% |
| 2026 | 19.55% | 12.03% |
| 2027 | 27.17% | 38.98% |
| 2028 | 27.83% | 2.43% |
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
11 Analysts have issued a Amgen forecast for earnings per share. The average Amgen <a href=/blog/eps>EPS is $8.61 . This is 23.18% higher than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is $14.80 111.73% , the lowest is $7.16 2.43% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2023 | $12.49 | 3.14% |
|---|---|---|
| 2024 | $8.61 | 31.06% |
| 2025 | $11.07 | 28.57% |
| 2026 | $12.64 | 14.18% |
| 2027 | $17.73 | 40.27% |
| 2028 | $18.31 | 3.27% |
P/E ratio
| Current | 44.46 | 176.84% |
|---|---|---|
| 2024 | 36.11 | 18.78% |
| 2025 | 28.08 | 22.24% |
| 2026 | 24.59 | 12.43% |
| 2027 | 17.53 | 28.71% |
| 2028 | 16.98 | 3.14% |
Based on analysts' sales estimates for 2024, the Amgen stock is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of 6.70 and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of 5.05 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 7.53 | 31.41% |
|---|---|---|
| 2024 | 6.70 | 11.03% |
| 2025 | 6.50 | 3.04% |
| 2026 | 6.37 | 1.88% |
| 2027 | 6.32 | 0.89% |
| 2028 | 6.26 | 0.82% |
P/S ratio
| Current | 5.68 | 24.20% |
|---|---|---|
| 2024 | 5.05 | 11.05% |
| 2025 | 4.90 | 3.04% |
| 2026 | 4.81 | 1.88% |
| 2027 | 4.76 | 0.89% |
| 2028 | 4.73 | 0.82% |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
